Cleavage of its extracellular domain leads to the detection of soluble E-selectin in serum, increased levels of which have been observed in subarachnoid hemorrhage [18], atherosclerosis [19], multiple sclerosis [20], end stage renal disease [21], and acute strokes [22]. This evidence concerns the gene SELE and atherosclerosis.